R47.1
Dysarthria and anarthria
Clinical Classification Guidelines
Excludes Type 1
- dysarthria following cerebrovascular disease (I69. with final characters -22)
Medical Intelligence & Overview
Dysarthria and anarthria are speech disorders that affect a person's ability to communicate effectively. Both conditions involve difficulties with speech production but differ in severity and underlying causes. Dysarthria refers to weak or difficult-to-control speech muscles, leading to slow, slurred, or muffled speech. Anarthria is a more severe form, resulting in the complete inability to produce understandable speech. Recognizing these conditions is important for appropriate management and support.
Causes & Symptoms
Clinical Causes: Neurological disorders such as stroke, Parkinson's disease, multiple sclerosis, or amyotrophic lateral sclerosis (ALS) Brain injuries from trauma or tumors that affect speech-related areas Degenerative diseases that impact the nervous system Certain infections or inflammatory conditions affecting the nervous system Congenital anomalies or developmental disorders
Key Symptoms: Slurred or slow speech (dysarthria) Inability to articulate words properly Difficulty controlling speech muscles, causing muffled or nasal speech In severe cases (anarthria), complete loss of speech production Difficulty with facial expressions and swallowing in some cases Potential accompanying weakness in speech muscles
Diagnostic & Treatment
Diagnosis Path: Diagnosing dysarthria and anarthria involves a comprehensive evaluation by a healthcare professional. This may include a detailed medical history, neurological examinations, and speech assessments to identify the specific nature of the speech impairments. Additional tests like MRI or CT scans may be used to examine brain structures and identify underlying neurological causes. Speech-language pathologists play a key role in assessing the severity and type of speech dysfunction.
Treatment Protocols: While these speech disorders may not be fully curable, various approaches can help improve communication abilities and quality of life. Treatment options include: - Speech and language therapy to strengthen speech muscles, improve clarity, and develop alternative communication strategies - Use of assistive communication devices or technology for those with severe impairments - Addressing underlying neurological conditions through medical management - Multidisciplinary approach involving neurologists, speech therapists, and other healthcare providers Support and adaptations at home and in social environments can also enhance communication and overall well-being.
Clinical Advice & FAQs
Billing Guidance
Is R47.1 a billable ICD-10 code?
Yes, R47.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R47.1?
Clinical documentation must specify the nature of Dysarthria and anarthria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference